Concepedia

Beverly S. Mitchell

BS

89

Publications

6.8K

Citations

49

H-Index

1979

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

University of Michigan

Stanford University

UNC Lineberger Comprehensive Cancer Center

Memorial Sloan Kettering Cancer Center

Beverly S. Mitchell is an author at University of North Carolina at Chapel Hill specializing in medicine, cell biology, and natural sciences.

ORCID

Top concepts

Publications per year

1979–2018

89

Publications

89

Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies

Robert Z. Orlowski, Thomas E. Stinchcombe, Beverly S. Mitchell et al. · Journal of Clinical Oncology · 2002 · 760 citations

Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies

Robert Z. Orlowski, Peter M. Voorhees, Reynaldo Garcia et al. · Blood · 2004 · 319 citations

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801

Daniel J. DeAngelo, Daohai Yu, Jeffrey L. Johnson et al. · Blood · 2007 · 307 citations · Full text

Association of DNA Polymerase μ (pol μ) with Ku and Ligase IV: Role for pol μ in End-Joining Double-Strand Break Repair

Kiran Mahajan, Stephanie A. Nick McElhinny, Beverly S. Mitchell et al. · Molecular and Cellular Biology · 2002 · 287 citations · Full text

, , +17

Phase I Study of 506U78 Administered on a Consecutive 5-Day Schedule in Children and Adults With Refractory Hematologic Malignancies

Joanne Kurtzberg, T J Ernst, Michael J. Keating et al. · Journal of Clinical Oncology · 2005 · 174 citations · Full text

Rows per page

1–5 of 89